| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.25 | 3e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |